Jeff Jones
Stock Analyst at Oppenheimer
(0)
# 4672
Out of 5,253 analysts
99
Total ratings
19.44%
Success rate
-17.27%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Evolent Health | Maintains: Outperform | 28 18 | 10.49 | 71.59% | 4 | Jan 24, 2025 | |
Cellectar Bioscience... | Downgrades: Perform | n/a | n/a | n/a | 5 | Dec 11, 2024 | |
Perspective Therapeu... | Maintains: Outperform | 22 16 | 3.62 | 341.99% | 7 | Nov 22, 2024 | |
Y-mAbs Therapeutics | Initiates Coverage On: Outperform | 23 | 5.99 | 283.97% | 1 | Nov 18, 2024 | |
Chemomab Therapeutic... | Reiterates: Outperform | 13 11 | 2.09 | 426.32% | 7 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 8 14 | 5 | 180% | 3 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 10 9 | 1.97 | 356.85% | 10 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 52 56 | 40.52 | 38.2% | 4 | Sep 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 35 39 | 28.63 | 36.22% | 2 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 87 89 | 32.02 | 177.95% | 1 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 48 45 | 10.85 | 314.75% | 6 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 80 88 | 9.57 | 819.54% | 8 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Perform | n/a | n/a | n/a | 4 | Jun 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 16 21 | 1.6 | 1212.5% | 2 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Perform | n/a | n/a | n/a | 3 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 32 30 | 30.96 | -3.1% | 3 | Feb 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 13 15 | n/a | n/a | 3 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Perform | n/a | n/a | n/a | 3 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 120 | 0.35 | 34185.71% | 3 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Perform | n/a | n/a | n/a | 2 | May 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 13 | n/a | n/a | 2 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 15 | 1.41 | 963.83% | 5 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 75 | 1.66 | 4418.07% | 2 | Mar 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 125 150 | n/a | n/a | 6 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 1600 1100 | 4.72 | 23205.08% | 2 | Nov 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Outperform | 193 | n/a | n/a | 1 | Jul 18, 2022 |